Theravance Biopharma, Inc. TBPH
$17.04
+0.06%
at last close
Financials (TTM)
- Revenue
- $104.31 million
- Net Income
- $53.81 million
- Net Margin
- 51.58%
- Return on Equity
- 18.57%
- Debt-to-Equity
- —
- P/E Ratio
- 16.87
- Price / Book
- 3.05
- Price / Sales
- 8.48
Over the trailing twelve months, Theravance Biopharma, Inc. generated revenue of $104.31 million and net income of $53.81 million, a net margin of 51.58%.
At the last closing price of $17.04, TBPH trades at 16.87 times trailing earnings and 8.48 times sales, with a market capitalization of $884.18 million.
Key Stats
- Last Close
- $17.04
- Market Cap
- $884.18 million
- 52-Week Range
- $10.82 – $21.03
- Average Volume
- 549K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.